Sompraz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a combination product containing lansoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori*. Lansoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics. ## Primary Indications Eradication of *Helicobacter pylori* in patients with duodenal or gastric ulcer disease. ## Adult Dosing **Standard Regimen:** One capsule (containing lansoprazole 30 mg, amoxicillin 1 g, and clarithromycin 500 mg) twice daily for 10 days. Alternatively, a common regimen is: * Lansoprazole 30 mg orally twice daily * Amoxicillin 1000 mg orally twice daily * Clarithromycin 500 mg orally twice daily *Note: Local resistance patterns may influence antibiotic choice and dosing. Consult local guidelines.* ## Pediatric Dosing Specific fixed-dose combination products for pediatric use are not universally established. Dosing for *H. pylori* eradication in pediatric patients is often individualized based on weight and local guidelines, typically using separate agents. * **Lansoprazole:** 1 mg/kg/day orally, divided into two doses, not to exceed 30 mg twice daily. * **Amoxicillin:** 50 mg/kg/day orally, divided into two doses, not to exceed 1 g twice daily. * **Clarithromycin:** 15 mg/kg/day orally, divided into two doses, not to exceed 500 mg twice daily. *Consult pediatric infectious disease specialists or current pediatric guidelines for specific recommendations.* ## Dose Adjustments * **Renal Impairment:** Lansoprazole does not typically require dose adjustment. Amoxicillin and clarithromycin may require dose reduction in severe renal impairment. Consult product labeling or renal dosing guidelines. * **Hepatic Impairment:** Lansoprazole, amoxicillin, and clarithromycin may require caution or dose adjustment in severe hepatic impairment. Consult product labeling or hepatic dosing guidelines. ## Contraindications * Hypersensitivity to any component of the formulation (lansoprazole, amoxicillin, clarithromycin, or other macrolides or penicillins). * History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use. * Concomitant use with ergot alkaloids. * Severe renal impairment with concomitant use of clarithromycin and colchicine. ## Adverse Effects Common adverse effects include: * **GI:** Diarrhea, nausea, abdominal pain, vomiting, taste disturbance. * **Other:** Headache, rash, fungal infections. Serious adverse effects can include: * *Clostridium difficile*-associated diarrhea (CDAD). * Hepatotoxicity (especially with clarithromycin). * Severe allergic reactions (anaphylaxis). * QT prolongation (especially with clarithromycin, particularly in patients with risk factors). ## Key Drug Interactions * **CYP3A4 Inhibitors/Inducers:** Clarithromycin is a moderate inhibitor of CYP3A4, potentially increasing serum concentrations of drugs metabolized by this enzyme (e.g., warfarin, certain statins, cyclosporine, tacrolimus, midazolam, ergot alkaloids). Co-administration with ergot alkaloids is contraindicated. * **PPIs:** Lansoprazole can decrease gastric acidity, potentially affecting the absorption of other drugs (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). * **Probenecid:** May decrease the renal excretion of amoxicillin and penicillin. * **Warfarin:** May increase INR and risk of bleeding. * **Colchicine:** Increased risk of colchicine toxicity with clarithromycin, especially in renal impairment. ## Monitoring * **Efficacy:** Monitor for resolution of symptoms. Confirm *H. pylori* eradication via stool antigen test, urea breath test, or biopsy 4-6 weeks after completing therapy. * **Adverse Effects:** Monitor for signs and symptoms of diarrhea, rash, hepatic dysfunction, and allergic reactions. * **Drug Interactions:** Assess for potential interactions based on concomitant medications. ## Clinical Pearls * This combination therapy is effective but requires strict adherence to the prescribed regimen for successful eradication. * Complete the full course of treatment, even if symptoms improve. * Advise patients to take medications as directed, typically with food to minimize GI upset. * Consider local antibiotic resistance patterns when selecting therapy, as resistance to clarithromycin can impact eradication rates. * If *H. pylori* is not eradicated after the first course, consider alternative salvage regimens. **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider for any health concerns or before making any treatment decisions.